MarketFriction

TTK Healthcare Ltd

NSE TTKHLTCARE · BSE 507747 · Diversified
₹1,013.00 -0.98%
NSE close2026-10-01
52 week range735.00 - 1,247.00
Market cap₹1,460 Cr.
P/E19.1
Price band 20% Delivery 56.6%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales186184181208198205190226204209218258
Expenses176179169201190197178224198202207243
Operating Profit10512788123571115
OPM %5%2.9%7%3.3%4.2%3.8%6%1.2%2.6%3.4%5%6%
Other Income161616371818131819102117
Interest101111111111
Depreciation333222222222
Profit before tax221824412323221821143029
Tax %26%27%25%23%26%26%26%26%4%25%26%26%
Net Profit161318321717161320112221
EPS in Rs11.339.1212.9322.3512.1711.8411.439.2014.437.4515.4015.06
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales519528578628646476599725753801857888
Expenses478489535578617457577694715767831850
Operating Profit403843502819223137352638
OPM %8%7%7%8%4.4%4.1%3.6%4.3%5.0%4.3%3.0%4.3%
Other Income66889284264363856867
Interest335332353333
Depreciation71215151413131313899
Profit before tax36293039193248657841088394
Tax %36%36%40%38%37%-44%13%3%25%25%20%
Net Profit2319182412464264063826674
EPS in Rs29.1924.1312.8617.258.7232.8729.43452.7244.4757.7946.4852.34
Dividend Payout %17%21%39%29%34%18%34%2%22%17%22%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth5%12%6%8%
Compounded Profit Growth12%11%-52%14%
Stock Price CAGR0%9%-4%-9%
Return on Equity19%22%7%6%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital888141414141414141414
Reserves1101281502192372352813169399871,0511,101
Borrowings423823472930192227232424
Other Liabilities115128104127136152180207189183192190
Total Liabilities2753032854074164314945591,1701,2061,2811,329
Fixed Assets52106991109889858071758173
CWIP4610129003101
Investments0109913913151313119
Other Assets1771851772883043253954631,0831,1181,1891,246
Total Assets2753032854074164314945591,1701,2061,2811,329
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity3937182517209645-25-5-4-21
Cash from Investing Activity-49-275-2210-13-77-3032282052
Cash from Financing Activity3-11-23-7-31-10-17-10-12-22-18-18
Net Cash Flow-7-00-4-4-425-62-213
Free Cash Flow-102112211389542-36-156-25
CFO/OP176%122%67%84%62%108%391%248%-28%54%68%-31%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days343324354743463346424147
Inventory Days62666580771011231028910510798
Days Payable505310013010112117013411611010683
Cash Conversion Cycle4646-11-162223-2119364363
Working Capital Days-31-38-24-30-6-3-32-2844948161
ROCE %20%23%18%15%15%8%6%8%10%9%9%8%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%74.57%
FIIs1.85%1.85%1.85%1.87%1.90%1.90%1.90%1.89%1.90%1.89%1.90%1.86%
DIIs3.23%3.13%1.14%1.14%1.14%1.14%1.14%1.18%1.18%1.08%1.11%2.19%
Public20.37%20.46%22.45%22.44%22.39%22.39%22.40%22.37%22.37%22.46%22.43%21.39%
No. of Shareholders15,67216,65117,22116,93015,76215,78015,89916,11216,13422,48123,68622,809

Fundamentals

Market Cap₹ 1,460 Cr.
Current Price₹ 1,034
Stock P/E19.1
Book Value₹ 789
ROCE8.04 %
ROE6.30 %
Dividend Yield0.97 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)8%
Compounded Profit Growth (TTM)14%
Standalone figures.
Valuation
Market capRs 1,431 Cr
Enterprise valueRs 822 Cr
P/E (TTM)19.35x
Price to book1.28x
Price to sales1.61x
EV / EBITDA7.82x
EV / EBIT8.52x
EV / sales0.93x
Earnings yield5.17%
Dividend yield0.99%
P/E, 3-year average23.23x
P/B, 3-year average1.53x
P/E, 5-year average20.04x
P/B, 5-year average1.94x
Profitability
Operating margin (excl. other income)3.05%
Operating margin (incl. other income)10.99%
EBITDA margin11.84%
Pre-tax margin10.55%
Net profit margin8.32%
Net margin, latest quarter8.26%
ROE6.03%
ROCE7.67%
ROA5.03%
ROE, 3-year average6.79%
ROCE, 3-year average8.97%
ROA, 3-year average5.63%
ROE, 5-year average26.68%
ROCE, 5-year average28.33%
ROA, 5-year average19.76%
ROIC (approx.)15.17%
Tax rate20.45%
Other income / net worth6.11%
Growth
Sales growth (latest year)6.96%
Profit growth (latest year)-19.57%
Sales CAGR, 3 years5.74%
Sales CAGR, 5 years12.48%
Profit CAGR, 3 years-53.17%
Profit CAGR, 5 years7.18%
Sales growth QoQ18.16%
Profit growth QoQ-2.21%
Sales growth YoY (latest quarter)13.75%
Profit growth YoY (latest quarter)63.69%
Per share
EPS (TTM)Rs 52.34
EPS (latest year)Rs 46.48
EPS (latest quarter)Rs 15.06
EPS, 3-year averageRs 49.58
EPS, 5-year averageRs 126.18
Book value per shareRs 788.98
Sales per shareRs 628.73
Cash flow per shareRs -14.97
Free cash flow per shareRs -17.69
Dividend per share (latest year)Rs 10.00
Dividend per share, 3-year averageRs 10.00
Dividend per share, 5-year averageRs 10.00
Dividends
Dividend payout21.51%
Dividend payout, 3-year average20.43%
Dividend payout, 5-year average19.50%
Efficiency
Asset turnover0.65x
Fixed asset turnover11.80x
Inventory turnover4.28x
Inventory days85 days
Debtor days47 days
Debtors turnover7.75x
Creditor days83 days
Cash conversion cycle63 days
Working capital days161 days
Leverage
Total debtRs 24 Cr
Cash and bankRs 633 Cr
Net debtRs -609 Cr
Debt to equity0.02x
Net debt / EBITDA-5.79x
Interest coverage35.86x
Current ratio (filing 2026-03-31)5.91x
Quick ratio (filing 2026-03-31)5.38x
Trade payables (filing 2026-03-31)Rs 91 Cr
Owners' fund to total sources83.90%
Debt to assets1.83%
Cash flow
Cash from Operating Activity (latest year)Rs -21 Cr
Cash from Investing Activity (latest year)Rs 52 Cr
Cash from Financing Activity (latest year)Rs -18 Cr
Net Cash Flow (latest year)Rs 13 Cr
Free cash flow (latest year)Rs -25 Cr
FCFE (approx.: FCF + change in debt)Rs -25 Cr
Cash from ops / profit, 5 years-0.01x
Statement figures
Net sales (TTM)Rs 888 Cr
Net sales (latest year)Rs 857 Cr
Sales (latest quarter)Rs 258 Cr
Operating profit excl. other income (latest year)Rs 26 Cr
Operating profit (latest quarter)Rs 15 Cr
Other income (TTM)Rs 67 Cr
EBITDA (TTM)Rs 105 Cr
PBDT (TTM)Rs 102 Cr
Profit before tax (TTM)Rs 94 Cr
Tax (latest year)Rs 17 Cr
Net profit (TTM)Rs 74 Cr
Net profit (latest year)Rs 66 Cr
Net profit (latest quarter)Rs 21 Cr
Depreciation (TTM)Rs 9 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 3 Cr
Cost of goods sold (latest year)Rs 466 Cr
Total expenditure (latest year)Rs 831 Cr
Total income (latest year)Rs 925 Cr
Share capitalRs 14 Cr
ReservesRs 1,101 Cr
Shareholders' fundsRs 1,115 Cr
Total assetsRs 1,329 Cr
Net blockRs 73 Cr
Capital work in progressRs 1 Cr
InvestmentsRs 9 Cr
ReceivablesRs 111 Cr
InventoryRs 109 Cr
Other liabilitiesRs 190 Cr
Shares outstanding (crore)1.41
Ownership
Promoter holding74.57% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 19.4 is at the 13th percentile of its own 9.4-year range (median 29.1, low 2.6, high 90.7).
P/B 1.28 is at the 4th percentile (median 2.82).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodTTKHLTCARENifty 50Difference
1 week-3.1%-2.8% -0.3 pts
1 month-10.3%-6.8% -3.5 pts
3 months+9.8%-7.6% +17.4 pts
6 months+37.0%+0.4% +36.6 pts
1 year-13.5%-9.9% -3.6 pts
2 years-39.6%-13.6% -26.1 pts
3 years-12.8%+14.2% -26.9 pts
5 years+51.8%+27.9% +23.9 pts

Red flags

F-score 4 of 8
explainWeak cash conversion Cash from operations was -14% of net profit over the last 3 years
lookProfit leans on other income Other income was 82% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹258 Cr +14.2% vs Jun 2025. Net profit ₹21 Cr +61.5%.
Against our estimate for Jun 2026: sales +5.4%, profit +10.3% in line. Our estimate for Sep 2026: sales Rs 233 Cr, profit Rs 21 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
3M India Ltd35,94081.550.0 %
Godrej Industries Ltd35,56129.68.17 %
DCM Shriram Ltd14,15610.311.5 %
Balmer Lawrie & Company Ltd2,7669.9114.6 %
Empire Industries Ltd63111.218.0 %
Maheshwari Logistics Ltd21814.312.0 %
Panth Infinity Ltd621.2732.9 %
Krypton Industries Ltd4716.811.4 %
Galactico Corporate Services Ltd3616.66.24 %
Swasti Vinayaka Art & Heritage Corporation Ltd295.9620.4 %
Billwin Industries Ltd1735.75.37 %
HCKK Ventures Ltd12-27.3 %
Alexander Stamps & Coin Ltd8-0.06 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-07-17Dividend - Rs 10 Per Share
2025-07-18Annual General Meeting/Dividend - Rs 10 Per Share
2024-07-16Annual General Meeting/Dividend - Rs10 Per Sh/
2023-07-18Annual General Meeting/Dividend - Rs 10 Per Share
2022-07-26Annual General Meeting/Dividend - Rs 10 Per Share
2021-08-12 Annual General Meeting/Dividend - Rs 6 Per Share
2020-09-03 Annual General Meeting/Dividend - Rs 3 Per Share
2019-08-01 Annual General Meeting/Dividend - Rs 5 Per Share
2018-08-02 Annual General Meeting/Dividend- Rs 5 Per Share
2017-07-27 Annual General Meeting/Dividend - Rs 5 Per Share
2016-07-28 Annual General Meeting/ Dividend - Rs 5 Per Share
DateTypeWhat it says
2026-09-04General UpdatesGeneral Updates
2026-09-02General UpdatesGeneral Updates
2026-08-27ResignationIntimation from M/s Aiyar & Co. regarding their Inability to continue as Tax Auditors w.e.f. August 26, 2026.
2026-08-06General UpdatesGeneral Updates
2026-08-06Board meeting outcomeTTK Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-07-24Shareholder meetingVoting results.
2026-07-24Shareholder meetingProceedings of Annual General Meeting held on July 24, 2026
2026-07-24General UpdatesGeneral Updates
2026-07-23Board meeting outcomeOutcome of Board Meeting held on July 23, 2026.
2026-07-23General UpdatesGeneral Updates
2026-06-27UpdatesBusiness Responsibility and Sustainability Report.
2026-06-27General UpdatesAnnual Report 2025-26
2026-06-27Shareholder meetingNotice of Annual General Meeting to be held on July 24, 2026
2026-06-17Disclosure under SEBI TakeovTTK Prestige Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substan...
2026-06-08Disclosure under SEBI TakeovTTK Healthcare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa...
2026-06-03Record DateRecord date for the purpose of Dividend is 17-Jul-2026.
2026-06-01General UpdatesGeneral Updates
2026-06-01Updates.
2026-05-30Board meeting outcomeTTK Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-05-30AppointmentAppointment of as Other of the company w.e.f. May 30, 2026.
2026-05-30General UpdatesGeneral Updates
2026-05-30Updates.
2026-05-30AppointmentAppointment of as Chairman of the company w.e.f. November 01, 2026.
2026-05-30DividendBoard of Directors at its meeting held on May 30, 2026, recommended Final Dividend of Rs. 10 per equity share.
2026-05-30Board meeting outcomeTTK Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of TTK Healthcare Ltd?

TTK Healthcare Ltd (TTKHLTCARE) has a market capitalisation of Rs 1,460 Cr. at the 2026-10-01 close.

What is the P/E ratio of TTK Healthcare Ltd?

TTK Healthcare Ltd trades at a P/E of 19.1 on trailing twelve-month profit, at the 2026-10-01 close.

What were TTK Healthcare Ltd's latest quarterly results?

In the Jun 2026 quarter, TTK Healthcare Ltd sales was Rs 258 Cr (+14.2% vs Jun 2025) and net profit was Rs 21 Cr.

What is the 52-week high and low of TTK Healthcare Ltd?

The 52-week high is Rs 1,247.00 and the 52-week low is Rs 735.00.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03